Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P910073/S189

RELIANCE S Active Fix Single Coil IS-1/DF-1 59cm (Model 0137); RELIANCE S Active Fix Single Coil IS-1/DF-1 64cm (Model 0

Boston Scientific · Decision date Apr 22, 2026

FDA DECISIONP910073/S189

What did the FDA decide?

FDA records P910073/S189 as a supplement to PMA P910073, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 22, 2026.

FDA approval order statement

an alternative vapor degreasing solvent used by a supplier, Integer Salem
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Apr 22, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P910073/S189
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
OK30
Decision date
Apr 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P910073. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P910073 · Original PMA

    ENDOTAK LEAD SYSTEM

  2. P910073/S176 · Related supplement

    ENDOTAK RELIANCE S, ENDOTAK RELIANCE, ENDOTAK RELIANCE SG, ENDOTAK RELIANCE G, RELIANCE 4-FRONT

  3. P910073/S183 · Related supplement

    ACC SUP CONNECTOR QUAD PSA TO IS4; ACC SUP SUTURE SLEEVE; ACC SUP KIT LD CAP; STRL PKG LEAD REPAIR KIT; ACC STY STR .016

  4. P910073/S186 · Related supplement

    RELIANCE 4-FRONT/model 0636; RELIANCE 4-FRONT/ model 0662; RELIANCE 4-FRONT/ model 0663 00802526592805 P910073; RELIANC

  5. P910073/S185 · Related supplement

    ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads

  6. P910073/S187 · Related supplement

    ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads

  7. P910073/S189 received

    Application receipt date recorded by FDA.

  8. P910073/S188 · Related supplement

    ACUITY X4 Connector Tool Model 4625 AICD Lead Stylets Firm Model 6971 AICD Lead Stylets Soft Model 6972 Suture S

  9. P910073/S189 · FDA decision

    30-Day Notice

  10. P910073/S190 · Related supplement

    ACUITY X4 Connector Tool (Model 4625); RELIANCE 4-FRONT Suture Sleeve (aka Lead Stabilizer) (Model 6403); Lead Cap Kit

  11. P910073/S191 · Related supplement

    Endotak Reliance Leads (0128, 0137, 0138, 0147, 0148, 0157, 0158); Endotak Reliance 4-Site Leads (0262, 0263, 0265, 0266

  12. P910073/S192 · Related supplement

    RELIANCE S Passive Single Coil, RELIANCE S Active Fix Single Coil, RELIANCE Passive Dual Coil, RELIANCE Active Fix Dual

Timeline entries are records held by MedtechLedger for P910073. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P910073

Product / regulatory recordCompanyPathwayDecision dateSource
Boston ScientificPMA approvalAug 26, 1993FDA
Boston ScientificPMA supplementAug 22, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementOct 24, 2025FDA
Boston ScientificPMA supplementFeb 13, 2026FDA
Boston ScientificPMA supplementFeb 20, 2026FDA
Boston ScientificPMA supplementMar 6, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 9, 2026FDA
Boston ScientificPMA supplementSep 17, 2026FDA

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific

Headquarters
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records